APPLICATIONS OF BOTULINUM TOXIN: TREATMENT OF VAGINISMUS AND VESTIBULODYNIA

View at publisher Summarise with VIRAT
Authors: Lokman Tekin Ertekin
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Vaginismus and vestibulodynia are two clinically challenging and frequently overlapping female sexual pain disorders that significantly impair sexual function, psychological well-being, and overall quality of life. Both conditions are commonly associated with pelvic floor muscle hypertonicity, involuntary muscle contraction, and persistent vulvovaginal pain, which may render vaginal penetration painful or entirely unachievable. Vaginismus is primarily defined by reflexive pelvic floor muscle spasm that interferes with penetration, whereas vestibulodynia is characterized by chronic pain localized to the vaginal vestibule, often exacerbated by touch or attempted intercourse. Despite differences in clinical presentation, these disorders frequently coexist and share overlapping neuromuscular and psychosocial mechanisms. Current clinical guidelines recommend conservative, multimodal strategies as first-line management, including psychosexual counseling, pelvic floor physiotherapy, pharmacological interven-tions, and structured vaginal dilator programs. Although many patients benefit from these approaches, a subset remains refractory to conventional treatment. In such cases, persistent pain, muscle spasm, and avoidance behaviors may perpetuate a self-sustaining pain-spasm cycle that is difficult to disrupt through conservative measures alone. In recent years, botulinum toxin type A (BoNT-A) has emerged as a promising minimally invasive therapeutic option for treatment-resistant vaginismus and vestib-ulodynia. By temporarily inhibiting acetylcholine release at the neuromuscular junction, BoNT-A in-duces targeted relaxation of hyperactive pelvic floor muscles, thereby reducing involuntary spasm and facilitating pain relief. Evidence suggests that BoNT-A injections, when administered to appropriately selected muscle groups or vestibular sites using precise techniques and individualized dosing protocols, may result in significant reductions in pain, improved tolerance of vaginal penetration, and meaningful enhancement of sexual function. Importantly, botulinum toxin therapy should not be regarded as a stand-alone cure. Optimal outcomes are achieved when BoNT-A is incorporated into a comprehensive, multi-disciplinary treatment framework that includes pelvic floor rehabilitation and behavioral interventions. This chapter reviews the scientific rationale, anatomical considerations, technical aspects, and clinical integration of botulinum toxin applications in the management of vaginismus and vestibulodynia, based on current evidence.

Fields of Study & Subjects

Sexual function and dysfunction studies Botulinum Toxin and Related Neurological Disorders Pelvic floor disorders treatments

Publication details

Journal / source
Turkiye Klinikleri eBooks
Pages
537–545
Publication date
1 January 2026
Language
EN
Document type
Book chapter